Ireland
--:--IST
Recruiting Not applicable

Spinal Versus General Anesthesia on Postoperative Pulmonary Complications

NCT06425627 · tracked via the Priya Life Science China tracker
Phase
Not applicable
Started
2024-06-12
Last updated
2025-09-17

Condition(s) studied

Pulmonary ComplicationAnesthesiaHip Fractures

Investigational drug(s) / intervention(s)

spinal anesthesiageneral anesthesia

spinal anesthesia: An intrathecal anesthetic technique.

general anesthesia: An intravenous (combined with inhalation) anesthetic technique.

Study summary

The objective of this study was to investigate the difference in postoperative pulmonary complications (PPCs) between spinal anesthesia and general anesthesia in patients undergoing delayed hip surgery.

Eligibility

Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients ≥ 65 years old * ASA Class I \~ III * Surgical repair of femoral neck, intertrochanteric or subtrochanteric fractures * The time from diagnosis to surgery is more than 48 hours Exclusion Criteria: * Unable to walk about 3 meters or across a room without assistance before the fracture * Emergency surgery * Congestive heart failure, asthma, anemia (Hb \< 90 g/L), hypoalbuminemia (ALB \< 35g/L) * Abnormal coagulation function * Severe aortic stenosis * Injection site infection or increased intracranial pressure * Patients have participated in previous trials or have been determined by a surgeon or anesthesiologist to be unsuitable for randomization * The written informed consent of the patient or his/her representative cannot be obtained

Primary outcome measure(s)

  • Arterial partial pressure of oxygen, PaO2 — 30 minutes after surgery
    PaO2 was measured by arterial blood gas analysis

Trial sites (1)

FacilityCityRegionStatus
Tianzhu Liu Wuhan Hubei Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06425627 on ClinicalTrials.gov ↗ ← All trials in China